| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 01, 2018 |
Chief Financial Officer
Trans History: 5
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,590 | -- | 59,590 |
| Oct 01, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,516 | -- | 10,516 |
| Sep 20, 2023 |
Chief Financial Officer
Trans History: 2
|
Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Mar 06, 2023 |
General Counsel
Trans History: 4
|
General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 39,270 |
| Mar 06, 2023 |
General Counsel
Trans History: 4
|
General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | 350,000 | -- | -- |
| Mar 06, 2023 |
General Counsel
Trans History: 4
|
General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | 117,810 | -- | -- |
| Feb 22, 2022 |
Director
Trans History: 3
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Chief Business Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Jun 08, 2021 |
Chief Commercial Officer
Trans History: 2
|
Chief Commercial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Sep 03, 2020 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.